Operating Expenses Cambiamento Data
Adma Biologics USD 80.47M 268K 2024-12
Alnylam Pharmaceuticals USD 698.32M 120.5M 2024-12
Dynavax Technologies USD 73.66M 3.12M 2024-12
Takeda JPY 1.08T 85.39B 2024-12



Adma Biologics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.